Cargando…

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

BACKGROUND: Biologicals, in combination with chemotherapy, are recommended as first-line treatment of metastatic colorectal cancer (mCRC); however, evidence guiding the appropriate management of older patients with mCRC is limited. OBJECTIVE: This study was undertaken to compare the efficacy and saf...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Alfonso, Pilar, Díaz-Rubio, Eduardo, Abad, Albert, Carrato, Alfredo, Massutí, Bartomeu, Ortiz-Morales, María José, Manzano Mozo, José Luis, Muñoz, Andrés, Durán, Gema, Sastre, Javier, Safont, María José, Ferreiro, Reyes, Rivera, Fernando, González, Encarnación, Valladares-Ayerbes, Manuel, Grávalos, Cristina, Alonso-Orduña, Vicente, Viéitez, José María, Yubero, Alfonso, Aranda, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914239/ https://www.ncbi.nlm.nih.gov/pubmed/33615402 http://dx.doi.org/10.1007/s40266-021-00834-w

Ejemplares similares

Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials
por: Benavides, Manuel, et al.
Publicado: (2019)

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients
por: Elez, Elena, et al.
Publicado: (2019)

Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study
por: Díaz-Rubio, Eduardo, et al.
Publicado: (2012)

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study
por: Garcia-Alfonso, Pilar, et al.
Publicado: (2015)

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial
por: Aranda, Enrique, et al.
Publicado: (2020)

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results
por: Salazar, Ramón, et al.
Publicado: (2020)

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study
por: Sastre, J., et al.
Publicado: (2021)

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features
por: Salazar, Ramon, et al.
Publicado: (2015)

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study
por: Conde, Elisa, et al.
Publicado: (2021)

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
por: Carrato, A., et al.
Publicado: (2019)

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
por: Martinez-Balibrea, E, et al.
Publicado: (2010)

Cobalt catalysed aminocarbonylation of thiols in batch and flow for the preparation of amides
por: Orduña, Jose Maria, et al.
Publicado: (2021)

Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
por: Peeters, Marc, et al.
Publicado: (2018)

Improving stool sample processing and pyrosequencing for quantifying benzimidazole resistance alleles in Trichuris trichiura and Necator americanus pooled eggs
por: Gandasegui, Javier, et al.
Publicado: (2021)

Analysis of Single Board Architectures Integrating Sensors Technologies †
por: Álvarez, José Luis, et al.
Publicado: (2021)

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015
por: Aranda, E., et al.
Publicado: (2015)

Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
por: Antolín, Silvia, et al.
Publicado: (2015)

Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study
por: Vera, Ruth, et al.
Publicado: (2020)

Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study
por: Valladares-Ayerbes, Manuel, et al.
Publicado: (2022)

Electrical Conductivity of a Stretching Viscoelastic Filament
por: Rubio, Manuel, et al.
Publicado: (2021)

A comparison between two brine shrimp assays to detect in vitro cytotoxicity in marine natural products
por: Carballo, José Luis, et al.
Publicado: (2002)

Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents
por: García-Alfonso, Pilar, et al.
Publicado: (2015)

Study of the Compatibilization Effect of Different Reactive Agents in PHB/Natural Fiber-Based Composites
por: Sánchez-Safont, Estefanía Lidón, et al.
Publicado: (2020)

Seom guidelines for the treatment of gastric cancer 2015
por: Martin-Richard, M., et al.
Publicado: (2015)

Erratum to: SEOM guidelines for the treatment of gastric cancer 2015
por: Martin-Richard, M., et al.
Publicado: (2016)

SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
por: Capdevila, Jaume, et al.
Publicado: (2022)

Correction to: SEOM‑GEMCAD‑TTD clinical guidelines for localized rectal cancer (2021)
por: Capdevila, Jaume, et al.
Publicado: (2022)

Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study
por: Martín-Richard, Marta, et al.
Publicado: (2013)

Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach
por: Blanco-Calvo, Moisés, et al.
Publicado: (2015)

Sample pooling for SARS-CoV-2 RT-PCR screening
por: de Salazar, Adolfo, et al.
Publicado: (2020)

Impact of Vegetable Oil Type on the Rheological and Tribological Behavior of Montmorillonite-Based Oleogels
por: Martín-Alfonso, M. A., et al.
Publicado: (2022)

Del artesanado al socialismo : selección de artículos /
por: González, José María (Sastre)
Publicado: (1974)

Disinfection of Reusable Laryngoscopes: A Survey about the Clinical Practice in Spain
por: Gómez-Ríos, Manuel Á., et al.
Publicado: (2023)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
por: Romero, Carolina, et al.
Publicado: (2021)

Macitentan for the Treatment of Refractory Digital Ulcers in Patients With Connective Tissue Diseases
por: Soto Abánades, Clara, et al.
Publicado: (2023)

Reflections on adjuvant treatment of gastric cancer
por: Abad, Albert, et al.
Publicado: (2007)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
por: Romero, Carolina, et al.
Publicado: (2022)

Hakai reduces cell-substratum adhesion and increases epithelial cell invasion
por: Rodríguez-Rigueiro, Teresa, et al.
Publicado: (2011)

Optical Coherence Tomography Angiography of Macula and Optic Nerve in Autism Spectrum Disorder: A Pilot Study
por: Garcia-Medina, Jose Javier, et al.
Publicado: (2020)

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy
por: Bonanno, Laura, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rmku757glni6faehlqtamct7vi